General
Methamphetamine Subcommittee Draft Reccomendations 08/23/2022
Opioid Safety - General
July 8, 2022
Methamphetamine Subcommittee Draft Reccomendations 08/23/2022
Draft Recommendation - Methamphetamine Subcommittee - Contingency Management - 2022
Draft Recommendation - Methamphetamine Subcommittee - Stimulant Treatment 2022
Draft Recommendation - Methamphetamine Subcommittee - Mobile Outreach Units 2022
Methamphetamine Subcommittee Recommendation Contingency Management 03/22/22
Opioid Safety - General
May 20, 2022
The State of New Mexico should mandate insurance carriers within the state to cover
Methamphetamine Subcommittee Recommendation Stimulant Treatment 03/22/22
Opioid Safety - General
May 20, 2022
The State of New Mexico should mandate insurance carriers within the state to cover medications prescribed by physicians for stimulant use disorder that have shown to be effective, are still in trial, and have otherwise had an improved outcome in reducing the use of methamphetamines.
2022 Submitted Public Comment to the CDC Clinical Practice Guideline for Prescribing Opioids
Opioid Safety - General
May 12, 2022
2022 Submitted Public Comment to the CDC Clinical Practice Guideline for Prescribing Opioids
Current Advisory Council Members List
Opioid Safety - General
February 21, 2022
Current Advisory Council Members List
Naloxone Standing Order for Opioid Treatment Centers/Programs
Opioid Safety - General
February 16, 2022
Naloxone Standing Order for Opioid Treatment Centers/Programs
Naloxone (or other opioid antagonist) Statewide Standing Order for Registered Pharmacists
Opioid Safety - General
January 26, 2022
Naloxone (or other opioid antagonist) Statewide Standing Order for Registered Pharmacists
Naloxone (or other opioid antagonist) Standing Order Prescription Hardcopy
Opioid Safety - General
January 26, 2022
Naloxone (or other opioid antagonist) Standing Order Prescription Hardcopy